Editorial Policy

Last Updated: September 1, 2026

Our Mission

The mission of iMedix is to provide accurate, accessible, and evidence-based health information to support informed decision-making. Our goal is to help readers better understand medical conditions, treatments, and healthcare options through reliable educational content grounded in current medical knowledge and clinical standards.

iMedix is a professionally produced and medically reviewed publication. It is not a community platform, a forum, or a patient network. Medical and editorial content on this site is attributed to an identified contributor or to the iMedix Editorial Team and passes the applicable editorial and medical review before publication. There is no route by which health content reaches a reader without going through that process.

iMedix content is intended for informational purposes only and does not replace professional medical advice, diagnosis, or treatment.

Content Creation Process

All medical content published on iMedix follows a structured editorial workflow designed to ensure accuracy, clarity, and clinical reliability.

Our publishing process typically includes:

Research and Topic Development: Topics are selected based on medical relevance, patient education needs, and public health importance using established medical literature and trusted clinical resources.
Content Writing: Articles are prepared by qualified medical writers, healthcare professionals, or experienced health editors trained in translating complex medical information for general audiences.
Medical Review: Licensed healthcare professionals evaluate medical accuracy, terminology, safety considerations, and clinical balance.
Editorial Review and Publication: Editors ensure readability, clarity, consistency, and adherence to iMedix editorial standards prior to publication.
Ongoing Monitoring and Updates: Published content is reassessed and updated when relevant clinical evidence, safety information, regulatory information, or clinical recommendations materially change.

Editorial Review and Medical Review Are Separate

Editorial review and medical review are performed by different people and serve different purposes. Each is a distinct step, and neither substitutes for the other.

Editorial review examines structure, clarity, readability, consistency of terminology, and compliance with iMedix publishing standards. Editors do not determine what is clinically correct.

Medical review examines whether the content is clinically accurate and safe for a general audience. It is performed by a licensed healthcare professional with relevant expertise, who is named on the published page.

An unresolved objection from a medical reviewer prevents publication. Editorial staff cannot overrule a medical reviewer on a question of clinical accuracy, and no editorial, commercial, or scheduling consideration releases content that has not cleared medical review.

What Medical Reviewers Verify

Medical review on iMedix is not a general impression of quality. A reviewer confirms, at minimum, that:

substantive clinical claims rest on an identified source, and each source supports what the text attributes to it,
indications, contraindications, interactions, and warnings match current approved product information and clinical guidance,
dosage figures, units, frequencies, and routes of administration are reproduced correctly,
safety information is presented in proportion to its clinical importance and is not softened, abbreviated, or moved out of view,
benefits and risks are presented in balance, without overstating efficacy or minimizing harm,
the text does not constitute individualized medical advice or invite a reader to self-treat,
the limits of the underlying evidence are stated where they are material.

Where a reviewer cannot verify a substantive clinical claim, the claim is corrected, supported by an appropriate source, or removed before publication. It is not published in hedged form on the strength of a qualifier alone.

Our Medical Review Team

Medical review on iMedix is conducted by licensed healthcare professionals selected according to strict qualification standards. Reviewers may include physicians, pharmacists, or other medical specialists with relevant clinical expertise and active professional experience.

Reviewers are assigned to subjects within their area of practice. A reviewer is never credited on content they did not examine, and reviewer attribution is not applied as a formatting convention or a template default.

Use of Artificial Intelligence (AI)

iMedix may utilize artificial intelligence tools to assist with research support, structural organization, or content outlining. However, iMedix does not publish AI-generated medical content without human oversight.

Specifically:

The output of an AI tool is never accepted as the basis for a clinical claim, a dosage figure, or a safety statement. Such material rests on the underlying medical source, never on what a tool produced from it.
An AI system is never treated as a source and is never cited as one. Any passage prepared with AI assistance is verified against the primary source by the named human author before it goes to medical review.
The named author carries the same accountability for AI-assisted text as for text written unaided.
AI assistance does not shorten, replace, or substitute for medical review.
Author and reviewer attributions are never generated, inferred, or completed by an automated process.

Article-Level Transparency and Attribution

Transparency is a core principle of the iMedix publishing model. Medical articles published under our current editorial standards clearly identify:

the author or medical writer responsible for content creation,
the licensed healthcare professional who performed the medical review,
publication, content update, and medical review dates where applicable.

Author and medical reviewer names link directly to individual professional profile pages presenting verified qualifications, clinical background, and areas of expertise, allowing readers to assess relevant expertise at the article level.

Our Authors

iMedix content is created by authors with demonstrated experience in healthcare communication, medical journalism, or clinical practice.

Authors are expected to:

accurately interpret scientific and clinical information,
present medical topics in clear, patient-friendly language,
follow evidence-based reporting principles,
avoid unsupported medical claims or speculative conclusions.

Medical content published under our current editorial standards undergoes the applicable editorial and medical review before publication.

Conflict of Interest

iMedix requires editorial staff, freelance authors, and medical reviewers to disclose any potential conflicts of interest. This includes financial relationships, advisory roles, consulting activities, or investments involving pharmaceutical, medical device, or healthcare companies.

If a relevant conflict of interest is identified, the contributor is excluded from authoring or reviewing content related to that subject.

Source Standards

iMedix prioritizes high-quality and clinically reliable sources when developing medical content. Preferred references include:

peer-reviewed medical journals,
clinical practice guidelines,
regulatory agency publications, including FDA, EMA, and comparable authorities,
recognized medical institutions and professional organizations,
current medical literature, with recency judged against the clinical question and against whether later work has superseded earlier findings.

Anecdotal evidence, promotional materials, or unverified health claims are not used as primary sources.

How Evidence Is Weighed

Not all published research carries the same weight, and treating it as though it does is a common source of misleading health content. Different sources also answer different questions: approved product information establishes what a medicine is authorized for and what safety information it must carry, while trials, systematic reviews, and clinical guidelines address different questions about efficacy, outcomes, and recommended practice. iMedix weighs evidence according to the question being answered.

On questions of regulatory status, approved indications, contraindications, and mandated warnings, current regulatory product information and safety communications are treated as the authoritative sources for the market the edition serves. On questions of efficacy, comparative effect, and clinical outcome, iMedix generally gives greater weight to the sources below in the order shown, while accounting for the quality of each study, how current it is, and how closely its population and design match the question being answered:

clinical practice guidelines issued by recognized professional bodies,
systematic reviews and meta-analyses of controlled trials,
individual randomized controlled trials,
observational and cohort studies,
case reports, mechanistic reasoning, and preclinical work.

Findings from the lower tiers are described as what they are. Preprints, conference abstracts, single small studies, and animal research are not presented as established evidence and are used only where they are the best available evidence and their status is stated in the text.

Uncertainty and Conflicting Evidence

Medical evidence is frequently incomplete or contested. Where that is the case, iMedix says so rather than selecting one position and presenting it as settled.

Where recognized guidelines disagree, the disagreement is described and the positions are attributed to their sources.
Where evidence is weak, preliminary, or drawn from small populations, the text says so at the point the claim is made, not only in a general disclaimer.
Where there is no reliable evidence, that absence is stated. Absence of evidence is not reported as evidence of harm or of benefit.
Efficacy is not implied through mechanism alone. That a treatment is biologically plausible is not reported as evidence that it works.

Medicines, Dosage, and Safety Information

Pages describing medicines are held to additional requirements because the consequences of an error on them can be immediate.

Indications, contraindications, interactions, and warnings are taken from current approved product information for the market the edition serves, and from the clinical guidance that applies to it.
Dosage information is reproduced as it appears in approved product information and attributed to it. iMedix does not adapt, extrapolate, or individualize a dose, and does not publish dosing for unapproved indications.
Where a medicine carries a boxed warning or a comparable safety restriction, the page states that it does and presents its substance prominently. Such warnings are not reduced to general cautions and are not moved below the material they qualify.
Regulatory status is stated for the market the edition serves. Where a product is not authorized in that market, the page says so explicitly rather than describing the product as though it were available.
Where a medicine is commonly obtained outside regulated supply, the risks of doing so are addressed directly, and no page provides guidance on obtaining a prescription-only medicine without a prescription.

User-Generated Content

iMedix does not publish user-generated health content or accept public submissions for publication.

As of August 2026, comments on medicine pages and the community Q&A section were permanently discontinued. Previously published questions, comments, and public community member accounts have been removed from the iMedix publishing system. New public accounts cannot be created for the purpose of submitting health content.

Profile pages on iMedix are reserved for authors, medical reviewers, and other professional contributors whose qualifications and backgrounds have been verified. A professional profile does not provide a public submission channel and does not represent participation in a community or patient network.

This change reflects iMedix’s current standards for medical accountability and provenance. Health information published on iMedix is expected to have identifiable authorship or editorial responsibility, appropriate medical review, and traceable supporting sources. Anonymous patient experiences, testimonials, comments, and community discussions are not presented alongside reviewed medical information as evidence or guidance.

If you have a question about a medical condition or treatment, consult a qualified healthcare professional. More information about this decision is available in our User Content Policy.

Accuracy and Content Updates

Maintaining accuracy is an ongoing responsibility. Articles may display publication, content update, or medical review dates indicating when the material was last evaluated or revised.

Content is reviewed and updated when:

a regulator approves, withdraws, restricts, or relabels a product covered on the page,
a safety communication, recall, or new warning is issued for it,
a relevant clinical guideline is published or revised,
new evidence materially changes the balance of benefit and risk described,
an error is identified, whether internally or by a reader.

Regulatory safety actions are treated as priority updates. Content affected by a material safety action is corrected, updated, or withdrawn from public view as appropriate before routine editorial work.

Readers may report potential inaccuracies through our official contact page.

Corrections Policy

If a factual or medical error is confirmed, iMedix corrects the content promptly. Significant corrections may be reflected directly within the article or accompanied by revision information where appropriate.

A correction is treated as medically significant when it changes a dosage, a contraindication, an interaction, a safety warning, a statement of regulatory status, or the clinical conclusion a reader would draw. Corrections of this kind are handled with priority, are re-examined by a medical reviewer rather than by editorial staff alone, and update the medical review date shown on the page where applicable. Corrections that do not affect meaning, such as typography or broken links, may be made without a revision note.

Reported issues are reviewed by the editorial team to ensure corrections align with current medical evidence and publishing standards.

Related Policies

This policy should be read together with the other documents describing how iMedix operates:

Our Independence Standard — the commitments that separate editorial judgement from commercial interests.
Advertising Policy — how iMedix generates advertising revenue, what advertising it accepts, and how placements are identified.
User Content Policy — why public health-content submissions are not published on iMedix.

Change Log

1 September 2026 — Updated the policy to reflect the completed removal of public user accounts, questions, and comments from the iMedix publishing system; aligned terminology, attribution language, and content-update standards with the current iMedix editorial model.
28 August 2026 — User-generated content discontinued across iMedix. Comments on medicine pages and the community Q&A section withdrawn, and removal of community member accounts begun. Policy expanded to state how evidence is weighed, what medical reviewers verify, how medicines and safety information are handled, how uncertainty is presented, and what qualifies as a medically significant correction. The User Content Policy was published alongside this revision.